Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy
V Shahabi, MA Postow, D Tuck… - American journal of …, 2015 - journals.lww.com
A clear contribution of the immune system to eradication of tumors has been supported by
recent developments in the field of immunotherapy. Durable clinical responses obtained …
recent developments in the field of immunotherapy. Durable clinical responses obtained …
[PDF][PDF] Overcoming therapeutic resistance in HER2-positive breast cancers with CDK4/6 inhibitors
Using transgenic mouse models, cell line-based functional studies, and clinical specimens,
we show that cyclin D1/CDK4 mediate resistance to targeted therapy for HER2-positive …
we show that cyclin D1/CDK4 mediate resistance to targeted therapy for HER2-positive …
MSVM-RFE: extensions of SVM-RFE for multiclass gene selection on DNA microarray data
X Zhou, DP Tuck - Bioinformatics, 2007 - academic.oup.com
Motivation: Given the thousands of genes and the small number of samples, gene selection
has emerged as an important research problem in microarray data analysis. Support Vector …
has emerged as an important research problem in microarray data analysis. Support Vector …
Macrophages Directly Contribute to the Exaggerated Inflammatory Response in Cystic Fibrosis Transmembrane Conductance Regulator−/− Mice
EM Bruscia, PX Zhang, E Ferreira… - American journal of …, 2009 - atsjournals.org
Pulmonary infection with an exaggerated inflammatory response is the major cause of
morbidity and mortality in cystic fibrosis (CF). The objective of this study was to determine …
morbidity and mortality in cystic fibrosis (CF). The objective of this study was to determine …
Association of COVID-19 vaccination with SARS-CoV-2 infection in patients with cancer: a US nationwide veterans affairs study
JTY Wu, J La, W Branch-Elliman, LB Huhmann… - JAMA …, 2022 - jamanetwork.com
Importance Patients with cancer are at increased risk for severe COVID-19, but it is unknown
whether SARS-CoV-2 vaccination is effective for them. Objective To determine the …
whether SARS-CoV-2 vaccination is effective for them. Objective To determine the …
Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1
W Lin, J Cao, J Liu, ML Beshiri… - Proceedings of the …, 2011 - National Acad Sciences
Aberrations in epigenetic processes, such as histone methylation, can cause cancer.
Retinoblastoma binding protein 2 (RBP2; also called JARID1A or KDM5A) can demethylate …
Retinoblastoma binding protein 2 (RBP2; also called JARID1A or KDM5A) can demethylate …
Prevalence and outcome of COVID-19 infection in cancer patients: a national Veterans Affairs study
NR Fillmore, J La, RE Szalat, DP Tuck… - JNCI: Journal of the …, 2021 - academic.oup.com
Background Emerging data suggest variability in susceptibility and outcome to coronavirus
disease 2019 (COVID-19) infection. Identifying risk factors associated with infection and …
disease 2019 (COVID-19) infection. Identifying risk factors associated with infection and …
A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis
T Paranjape, H Heneghan, R Lindner, FK Keane… - The lancet …, 2011 - thelancet.com
Background We previously identified a functional variant in a let-7 microRNA (miRNA)
complementary site in the 3′-untranslated region of the KRAS oncogene (rs61764370) …
complementary site in the 3′-untranslated region of the KRAS oncogene (rs61764370) …
[PDF][PDF] Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.
L Welles, MW Saville, J Lietzau, JM Pluda… - Journal of Clinical …, 1998 - researchgate.net
Purpose: To investigate the antitumor activity and safety of paclitaxel in patients with
advanced human immunodeficiency virus (HIV)-associated Kaposi's sarcoma (KS). Patients …
advanced human immunodeficiency virus (HIV)-associated Kaposi's sarcoma (KS). Patients …
Dual HDAC and PI3K inhibitor CUDC-907 downregulates MYC and suppresses growth of MYC-dependent cancers
K Sun, R Atoyan, MA Borek, S Dellarocca… - Molecular cancer …, 2017 - AACR
Upregulation of MYC is a common driver event in human cancers, and some tumors depend
on MYC to maintain transcriptional programs that promote cell growth and proliferation …
on MYC to maintain transcriptional programs that promote cell growth and proliferation …